4th Quarter - Report
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for GENERIC PHARMACEUTICAL ASSOCIATION
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY L JOHNSON | Former Member of Congress |
| LANCE B LEGGITT | Spec,. Asst to the President for Domestic Policy |
| SARA LOVE RAWLINGS | the Senate Appropriations Committee |
| JENNIFER SUMMA | — |
Copyright/Patent/Trademark CPT
Issues relating to patent settlements including S. 214, Preserve Access to Generics Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| NANCY L JOHNSON | Former Member of Congress |
| LANCE B LEGGITT | Spec. Asst to President for Domestic Policy |
| SARA LOVE RAWLINGS | the Senate Appropriations Committee |
| JENNIFER SUMMA | — |
Pharmacy PHA
Issues relating to biosimilar regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE B LEGGITT | Spec. Asst to President on Domestic Policy |
| SARA LOVE RAWLINGS | the Senate Appropriations Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.